Mannkind Corp

Ownership Transactions Reported by 18 Insiders

Symbol
MNKD on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 Casper Street, Danbury, Connecticut

Insiders trading volume in the past year

Mannkind Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Castagna Chief Executive Officer, Director $14.5M -$1.42M -8.95% Aug 27, 2024
Stuart A. Tross Chief People & Workpl Officer $6.4M -$663K -9.38% Sep 3, 2024
Steven B. Binder EVP Special Projects $6.39M -$183K -2.79% Aug 27, 2024
David Thomson EVP Genl Counsel & Secretary $4.93M -$174K -3.41% Aug 27, 2024
Alejandro Galindo EVP Endocrine Business Unit $3.11M Aug 22, 2022
Joseph Kocinsky Chief Technology Officer $2.98M Aug 27, 2022
Sanjay R. Singh EVP Technical Operations $2.35M Jul 15, 2024
Lauren M. Sabella EVP Chief Operating Officer $2.18M Jul 15, 2024
Ronald J. Consiglio Director $1.79M May 15, 2024
Burkhard Blank EVP Chief Medical Officer $1.68M May 24, 2024
Christopher Prentiss Chief Financial Officer $1M May 15, 2024
Sabrina Kay Director $869K May 15, 2024
Anthony C. Hooper Director $576K May 15, 2024
Jennifer Grancio Director May 15, 2024
Kent Kresa Director May 15, 2024
Michael A. Friedman Director May 15, 2024
Christine Mundkur Director May 15, 2024
James Samuel Shannon Director May 15, 2024

Recent Insider Transactions by Companies or Individuals for Mannkind Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.